These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29769697)

  • 1. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation.
    Yip YL; Lin W; Deng W; Jia L; Lo KW; Busson P; Vérillaud B; Liu X; Tsang CM; Lung ML; Tsao SW
    Lab Invest; 2018 Aug; 98(8):1093-1104. PubMed ID: 29769697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
    Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
    Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma.
    Chai AWY; Yee SM; Lee HM; Abdul Aziz N; Yee PS; Marzuki M; Wong KW; Chiang AKS; Chow LK; Dai W; Liu TF; Tan LP; Khoo ASB; Lo KW; Lim PVH; Rajadurai P; Lightfoot H; Barthorpe S; Garnett MJ; Cheong SC
    Cancer Res Commun; 2024 Mar; 4(3):645-659. PubMed ID: 38358347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM; Tsao SW
    Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
    Shi F; Shang L; Zhou M; Lv C; Li Y; Luo C; Liu N; Lu J; Tang M; Luo X; Xu J; Fan J; Zhou J; Gao Q; Wu W; Jia W; Wang H; Cao Y
    J Med Virol; 2024 May; 96(5):e29634. PubMed ID: 38682578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
    Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
    Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.
    Fang CY; Lee CH; Wu CC; Chang YT; Yu SL; Chou SP; Huang PT; Chen CL; Hou JW; Chang Y; Tsai CH; Takada K; Chen JY
    Int J Cancer; 2009 May; 124(9):2016-25. PubMed ID: 19132751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells.
    Fang CY; Huang SY; Wu CC; Hsu HY; Chou SP; Tsai CH; Chang Y; Takada K; Chen JY
    PLoS One; 2012; 7(9):e44810. PubMed ID: 23024765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
    Lin W; Yip YL; Jia L; Deng W; Zheng H; Dai W; Ko JMY; Lo KW; Chung GTY; Yip KY; Lee SD; Kwan JS; Zhang J; Liu T; Chan JY; Kwong DL; Lee VH; Nicholls JM; Busson P; Liu X; Chiang AKS; Hui KF; Kwok H; Cheung ST; Cheung YC; Chan CK; Li B; Cheung AL; Hau PM; Zhou Y; Tsang CM; Middeldorp J; Chen H; Lung ML; Tsao SW
    Nat Commun; 2018 Nov; 9(1):4663. PubMed ID: 30405107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
    Cheung ST; Huang DP; Hui AB; Lo KW; Ko CW; Tsang YS; Wong N; Whitney BM; Lee JC
    Int J Cancer; 1999 Sep; 83(1):121-6. PubMed ID: 10449618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
    Novalić Z; Verkuijlen SAWM; Verlaan M; Eersels JLH; de Greeuw I; Molthoff CFM; Middeldorp JM; Greijer AE
    J Med Virol; 2017 Dec; 89(12):2207-2216. PubMed ID: 28853217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.